Scleromyxedema in an adult following Sinopharm BBIBP-CorV vaccination: An extremely rare phenomenon.

Amirhossein ParsaeiSomayeh Sadat RezaeiAlireza RahmaniMaryam MasoumiHojat DehghanbanadakiSomayyeh NorouziMohammad Mehdi RiyahiReihane TabaraiiSeyed Mohammad Hashem Montazeri

Published in: Journal of scleroderma and related disorders (2022)

This study emphasizes the need of considering scleromyxedema as a connective tissue pathology in patients who have recently received Sinopharm vaccine and have similar cutaneous signs.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes